Cambridge Investment Research Advisors, Inc.
Position in CHRS — Coherus Oncology, Inc.
CIK 1419186
FAIRFIELD, IA
Position in CHRS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$73,326
-$317 QoQ
Shares Held
52,376
+20.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 145 holders
Holding Since
Jun 2021
21 quarters on record
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. CHRS ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in CHRS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,326 | 52,376 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $73,643 | 43,576 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $62,024 | 43,679 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $82,037 | 50,023 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $35,653 | 48,773 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $41,780 | 51,773 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $66,372 | 48,096 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,427 | 15,796 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $33,882 | 19,585 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $58,896 | 24,643 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $683,126 | 205,143 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $86,326 | 23,082 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $92,565 | 21,678 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $148,277 | 21,678 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $134,465 | 16,978 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $145,860 | 15,178 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $112,784 | 15,578 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $201,111 | 15,578 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $248,624 | 15,578 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $279,264 | 17,378 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $243,103 | 17,578 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||